Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
For full access to this article login to GEN Select now.
Progress in Stem Cell Pluripotency
From our January 15 issue: Translational applications of pluripotency are gaining momentum, despite developmental, regulatory, and advocacy challenges.
- The stem cell world finds itself at a critical juncture as the new year begins. That’s the view of Paul Knoepfler, Ph.D., associate professor at the UC Davis School of Medicine. Last month he moderated one of the sessions at the Genetics Policy Institute’s“World Stem Cell Summit.” “The ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.